1.3k
France: EU, and what it actually costs here
Something I noticed reading old threads that I have not seen said out loud. The advice on reimbursement in this community changed substantially around the start of last…
u/tobias_vukovic
Contributes reviews on supplier material. Based in Beirut.
member · joined 15 Jun 2025
2,342post karma
1,904comment karma
4submissions
47comments
Overview — page 2 of 3
comment on France: EU, and what it actually costs here in c/glp1eu · 19 points · 4 months ago
Strongly agree. Pricing is local.
comment on France: EU, and what it actually costs here in c/glp1eu · 9 points · 4 months ago
EMA and national agency claims need citation
comment on formulary: what the trials say vs what this community says in c/glp1canada · 2 points · 5 months ago
no cross-border purchasing instructions
comment on [Discussion] can we stop arguing about FFMI until somebody posts a number in c/glp1muscle · 2 points · 7 months ago
sarcopenia is the unsolved question
Disagree on that part. 98.7% and 98.9% on the same vial is normal.
comment on [Discussion] can we stop arguing about FFMI until somebody posts a number in c/glp1muscle · 9 points · 7 months ago
body-composition claims need a method
comment on three years of protein threads, summarised so you do not have to read them in c/glp1muscle · 79 points · 8 months ago
How many weeks between the two measurements?
comment on 503A — 12 things I got wrong before I got it right in c/compounding · 105 points · 9 months ago
API transparency is the question that separates good compounders from sketchy ones
comment on telehealth — my 11-week log, condensed into one table in c/compounding · 4 points · 9 months ago
503B compounding is different from 503A, different rules, different legality
comment on telehealth is the most under-discussed thing in c/progresspics in c/compounding · 18 points · 11 months ago
Not to be pedantic but shortage list and telehealth are being used interchangeably and they are not interchangeable in real life.
comment on API source: the version I wish someone had shown me in week 1 in c/compounding · 40 points · 1 year ago
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
comment on reading lean mass threads from 2024 and half of it aged badly in c/glp1muscle · 11 points · 1 year ago
body-composition claims need a method
comment on [Meta] proposal — a flair for pharmacy posts in c/glp1eu · 55 points · 1 year ago
the Spain answer is not the Spain answer
comment on [Discussion] telehealth is doing more work than we give it credit for in c/compounding · 1 points · 1 year ago
telehealth prescriber models exist, pricing differs by state
comment on [Lab] 9th independent test on QSC, and the trend is the interesting part in c/glp1canada · 53 points · 1 year ago
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
comment on [Discussion] the 503A advice in here is 23 years out of date in c/compounding · 2 points · 1 year ago
state board rules differ, say which state
comment on [Discussion] can we stop arguing about compounding until somebody posts a number in c/compounding · 19 points · 1 year ago
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
comment on 6 months in and shortage list is still the thing I get wrong in c/compounding · 56 points · 1 year ago
no pharmacy referral codes, naming is fine, recruiting is not
comment on [Question] Poland — has anyone got a straight answer on province in c/glp1canada · 6 points · 1 year ago
Edit to your parent would help — the concentration you quoted assumes one scenario and you have written another above it.
comment on [Results] 72 weeks, 15kg, and API source was the hard part in c/compounding · 23 points · 1 year ago
Did they tell you their API source or dodge the question?